Table 1. Baseline characteristics of the study participants. Values are means (±SE) or counts (%).
DHA(n=14) Placebo(n=13) Between-groupP-value
Age, yr 31.9 (3.1) 33.3 (2.4 .73
Height, m 1.63 (.02) 1.68 (.01) .07
Weight, kg 60.3 (2.8) 66.1 (4.8) .30
BMI, kg·m-2 22.7 (1.1) 23.5 (1.6) .67
1RM, kg 6.1 (.3) 6.5 (.4) .39
120% 1RM, kg 7.3 (.4) 7.8 (.4) .39
Active participation in strength training, number of subjects 0 (0%) 0 (0%) 1.00
Active participation in endurance exercise training, number of subjects 5 (36%) 2 (15%) .24
*Frequency endurance exercise, sessions/week 3(2) 3(2) .54
Pill Compliance (%) 94 (2.7) 95 (1.9) .84
BMI, body mass index; 1RM, one repetition maximum. Between-group p-values are from independent t-tests for quantitative data or Fisher’s exact tests for frequencies.